Skin Proteomic Analysis of Immune Activation Associated with Regression of Melanoma Metastases Induced by Diphencyprone

Name: Skin Proteomic Analysis of Immune Activation Associated with Regression of Melanoma Metastases Induced by Diphencyprone
Creator: Joseph Han
Published: 2022-08-17T20:25:17.188Z
Keywords: Proteomics, Biomarkers, Clinical Trial, Diphencyprone, Metastasis, Melanoma

Han, Joseph; Correa da Rosa, Joel; Owji, Shayan; Yassky, Daniel; Luu, Yen; Estrada, Yeriel; Ungar, Jonathan; Ji, Andrew; Krueger, James G; Gulati, Nicholas

doi:10.17632/f5ttw4mygy.1

Skin Proteomic Analysis of Immune Activation Associated with Regression of Melanoma Metastases Induced by Diphencyprone

Published: 17 August 2022| Version 1 | DOI: 10.17632/f5ttw4mygy.1

Contributors:

Joseph Han, Joel Correa da Rosa, Shayan Owji, Daniel Yassky, Yen Luu, Yeriel Estrada, Jonathan Ungar, Andrew Ji, James G Krueger, Nicholas Gulati

Description

Supplementary Data for Skin Proteomic Analysis of Immune Activation Associated with Regression of Melanoma Metastases Induced by Diphencyprone

Files

Institutions

Icahn School of Medicine at Mount Sinai

Skin Proteomic Analysis of Immune Activation Associated with Regression of Melanoma Metastases Induced by Diphencyprone

Description

Files

Institutions

Categories

Licence